[Vericiguat-new treatment option for patients with heart failure : Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction (VICTORIA)]

Internist (Berl). 2020 Sep;61(9):989-991. doi: 10.1007/s00108-020-00828-7.
[Article in German]
No abstract available

MeSH terms

  • Heart Failure / drug therapy*
  • Heart Failure / metabolism
  • Heart Failure / physiopathology
  • Heterocyclic Compounds, 2-Ring / administration & dosage*
  • Humans
  • Pyrimidines / administration & dosage*
  • Soluble Guanylyl Cyclase / drug effects
  • Soluble Guanylyl Cyclase / metabolism*
  • Stroke Volume / physiology*
  • Treatment Outcome
  • Ventricular Dysfunction, Left / complications
  • Ventricular Dysfunction, Left / drug therapy*

Substances

  • Heterocyclic Compounds, 2-Ring
  • Pyrimidines
  • Soluble Guanylyl Cyclase
  • vericiguat